US Neuropathy Centers
2 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Can the Phoenix Sign be Elicited With D5W (NCT07568470) | US Neuropathy Centers | 2026-04-10 |
| The Investigators Are Comparing Lidocaine and Papaverine Nerve Blocks to Determine Which Improves Blood Flow Better, Making the "Phoenix Sign" Clearer on Imaging. This Helps Accurately Diagnose Nerve Compression, Improving Patient Care (NCT06919289) | US Neuropathy Centers | 2024-03-07 |
Track US Neuropathy Centers automatically
Every clearance here is in the API, with alerts when new ones post.